Stay updated on Intranasal Etripamil Safety Study for PSVT Clinical Trial
Sign up to get notified when there's something new on the Intranasal Etripamil Safety Study for PSVT Clinical Trial page.

Latest updates to the Intranasal Etripamil Safety Study for PSVT Clinical Trial page
- Check2 days agoChange DetectedLocations section expanded to include sites across multiple US states and Canadian provinces. Revision updated from v3.3.2 to v3.3.3.SummaryDifference2%

- Check9 days agoNo Change Detected
- Check16 days agoNo Change Detected
- Check30 days agoChange DetectedThese publications are automatically filled from PubMed and may not all be about the study; the revision identifier was updated from v3.2.0 to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check37 days agoChange DetectedThe government funding/operating status notice was removed from the page, a generic site-wide alert that did not affect the study details or data. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check52 days agoChange DetectedNo substantive changes detected between the two screenshots. The page still centers on the NODE-302 safety study of etripamil nasal spray for PSVT.SummaryDifference0.3%

- Check80 days agoChange DetectedThe page now includes an operating-status notice and a version update to v3.2.0, while removing the previous v3.1.0 reference.SummaryDifference3%

- Check88 days agoChange DetectedUpdated the page from Revision: v3.0.2 to Revision: v3.1.0, signaling a new release version.SummaryDifference0.1%

Stay in the know with updates to Intranasal Etripamil Safety Study for PSVT Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Intranasal Etripamil Safety Study for PSVT Clinical Trial page.